You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 19, 2024

Investigational Drug Information for SAGE-718


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug SAGE-718?

SAGE-718 is an investigational drug.

There have been 11 clinical trials for SAGE-718. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2022.

The most common disease conditions in clinical trials are Cognitive Dysfunction, Huntington Disease, and Dementia. The leading clinical trial sponsors are Sage Therapeutics and [disabled in preview].

Recent Clinical Trials for SAGE-718
TitleSponsorPhase
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)Sage TherapeuticsPhase 2
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's DiseaseSage TherapeuticsPhase 3
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentSage TherapeuticsPhase 2

See all SAGE-718 clinical trials

Clinical Trial Summary for SAGE-718

Top disease conditions for SAGE-718
Top clinical trial sponsors for SAGE-718

See all SAGE-718 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.